Plant protection products (“PPPs”) are defined in legislation in a broad and highly technical manner. They include preparations used to protect plants and plant products against harmful organisms or to prevent their effects, excluding products intended solely for plant nutrition. These products may also influence plant growth, control or prevent undesirable developments, or eliminate unwanted plants, and typically consist of one or more active ingredients that work…
»
Following the structural changes introduced in 2023 to the regulatory framework governing health claims on food and dietary supplements, the subsequent period has been characterised less by new legislative intervention and more by regulatory consolidation and practical implementation. The removal of mandatory prior administrative approval for health claims has remained in effect, reshaping the compliance landscape by shifting greater responsibility onto economic…
»
In July 2025, Türkiye introduced Law No. 7557, bringing wide-ranging updates to the healthcare system. These reforms aim to modernise services, improve efficiency, and strengthen oversight, responding to growing healthcare demands and technological developments.
For the life sciences sector, several provisions are particularly relevant:
Physicians and dentists are now limited to practicing in a maximum of two healthcare institutions, marking a shift toward tighter workforce…
»
Recent regulatory developments in the medical devices sector point to a shift from procedural compliance toward enforcement-driven market discipline, coupled with a gradual restructuring of technical service governance.
A major inflection point in this trajectory was the entry into force of Law No. 7557 in July 2025, which introduced Additional Article 20 to the Basic Law on Health Services. This provision significantly expanded the administrative sanctions framework…
»
Interactions between life sciences companies and healthcare professionals (“HCPs”) in Türkiye continue to be governed by a well-established regulatory framework. In the pharmaceutical sector, promotional activities remain subject to the Regulation on the Promotion of Medicinal Products for Human Use, which strictly limits promotion to healthcare professionals and prohibits direct or indirect advertising to the public. Engagements such as consultancy and service arrangements…
»
Counterfeit and illicitly traded health products remained a persistent concern in Türkiye throughout 2025, as reflected both in enforcement statistics and in external reporting on supply chain integrity. Despite the legal prohibition on the online sale of pharmaceutical products, there has been a noticeable increase in the circulation of counterfeit medicines through online channels, alongside growing reports of products being illicitly exported from Türkiye to foreign…
»
